Conventional CD4+CD127loFoxP3+ Tregs and unconventional CD4+CD127hiFoxP3+ Tregs expressing cytotoxicity markers CD107 and FasL have been described in lymphoma and CLL patients (73). The gene discussed is CD4; the disease is B-cell chronic lymphocytic leukemia.